GSK1557484A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK1557484A, covering 2014-03-31 to 2019-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age [Phase 2]